Precision Wealth Strategies’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,623
Closed -$223K 119
2024
Q1
$223K Buy
5,623
+413
+8% +$16.3K 0.21% 89
2023
Q4
$206K Sell
5,210
-34
-0.6% -$1.42K 0.2% 81
2023
Q3
$233K Buy
5,244
+113
+2% +$4.93K 0.25% 73
2023
Q2
$223K Sell
5,131
-124
-2% -$5.45K 0.37% 57
2023
Q1
$229K Sell
5,255
-199
-4% -$8.79K 0.36% 59
2022
Q4
$203K Sell
5,454
-77
-1% -$2.98K 0.21% 97
2022
Q3
$225K Sell
5,531
-50
-0.9% -$1.85K 0.2% 111
2022
Q2
$203K Buy
5,581
+242
+5% +$8.75K 0.16% 134
2022
Q1
$212K Sell
5,339
-731
-12% -$28.6K 0.13% 163
2021
Q4
$252K Buy
6,070
+513
+9% +$22.3K 0.18% 114
2021
Q3
$234K Buy
+5,557
New +$280K 0.18% 111

Other funds holding NRC

Precision Wealth Strategies's NRC Position: Q2 2024 in Review

Precision Wealth Strategies sold out of NRC Health Common Stock (NRC) in Q2 2024, closing a stake of 5,623 shares — an estimated $223K sold.

Precision Wealth Strategies first reported a position in NRC in Q3 2021 and held it in 11 quarters. The position peaked at $252K in Q4 2021. 136 funds tracked by Wall St. Rank hold NRC as of Q2 2024.

  • Precision Wealth Strategies reported no remaining NRC Health Common Stock position as of Q2 2024 after selling out during the quarter.
  • Precision Wealth Strategies sold 5,623 NRC Health Common Stock shares in Q2 2024, an estimated $223K.
  • Precision Wealth Strategies first reported a position in NRC Health Common Stock in Q3 2021 and held it in 11 quarters.
  • Precision Wealth Strategies's NRC Health Common Stock position peaked at $252K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2024.

Based on Precision Wealth Strategies's 13F filing for Q2 2024, filed 5 Aug 2024.